Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
MLAB 
Mesa Laboratories Inc (MLAB)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/09/2026: MLAB (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $99
1 Year Target Price $99
| 2 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -53.96% | Avg. Invested days 25 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 01/09/2026 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 465.42M USD | Price to earnings Ratio - | 1Y Target Price 99 |
Price to earnings Ratio - | 1Y Target Price 99 | ||
Volume (30-day avg) 4 | Beta 0.89 | 52 Weeks Range 55.21 - 154.03 | Updated Date 01/9/2026 |
52 Weeks Range 55.21 - 154.03 | Updated Date 01/9/2026 | ||
Dividends yield (FY) 0.73% | Basic EPS (TTM) -0.31 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -0.64% | Operating Margin (TTM) 7.78% |
Management Effectiveness
Return on Assets (TTM) 2.13% | Return on Equity (TTM) -0.93% |
Valuation
Trailing PE - | Forward PE 35.21 | Enterprise Value 655362859 | Price to Sales(TTM) 1.9 |
Enterprise Value 655362859 | Price to Sales(TTM) 1.9 | ||
Enterprise Value to Revenue 2.67 | Enterprise Value to EBITDA 15.2 | Shares Outstanding 5522299 | Shares Floating 5349009 |
Shares Outstanding 5522299 | Shares Floating 5349009 | ||
Percent Insiders 5.44 | Percent Institutions 92.7 |
Upturn AI SWOT
Mesa Laboratories Inc
Company Overview
History and Background
Mesa Laboratories, Inc. was founded in 1982. It has grown from a single product to a diversified provider of critical quality control and calibration products and services for a wide range of industries, including pharmaceutical, medical device, industrial, and environmental. The company has a history of strategic acquisitions to expand its product lines and market reach.
Core Business Areas
- Sterilization and Biologics: This segment focuses on providing equipment and consumables for sterilization processes used in healthcare and pharmaceutical manufacturing, as well as products for biological testing and research.
- Calibration Services: Mesa offers calibration services for a variety of instruments and equipment, ensuring accuracy and compliance with regulatory standards across different industries.
- Specialty Products: This segment includes a diverse range of products such as biological indicators, chemical indicators, incubators, and data loggers used in quality control and validation processes.
Leadership and Structure
Mesa Laboratories Inc. is led by a management team with extensive experience in their respective industries. The organizational structure is designed to support its diverse product lines and service offerings, often operating through distinct divisions or business units.
Top Products and Market Share
Key Offerings
- Biological Indicators: Crucial for validating the efficacy of sterilization processes (steam, EtO, VHP, dry heat) in healthcare and pharmaceutical settings. Competitors include 3M, Terragene, and SPS Medical. Market share data is not publicly disclosed but is significant within its niche.
- Chemical Indicators: Used to visually confirm that sterilization conditions have been met. Competitors include 3M, Terragene, and Nelson Labs. Market share data is not publicly disclosed but is significant within its niche.
- Incubators and Data Loggers: Essential for monitoring and recording sterilization cycles and environmental conditions. Competitors vary by product type but include companies like Zirkonzahn, Thermo Fisher Scientific, and Vaisala.
Market Dynamics
Industry Overview
Mesa Laboratories operates in the highly regulated fields of healthcare, pharmaceuticals, and industrial quality control. The demand for its products and services is driven by stringent regulatory requirements, the need for product safety, and the growing complexity of manufacturing processes.
Positioning
Mesa Laboratories is positioned as a provider of mission-critical quality control and calibration solutions. Its competitive advantages lie in its established reputation for reliability, deep regulatory expertise, and a comprehensive product portfolio that addresses critical needs in sterilization validation and calibration.
Total Addressable Market (TAM)
The TAM for sterilization validation, biological and chemical indicators, and calibration services is substantial, driven by global healthcare spending, pharmaceutical manufacturing growth, and industrial quality assurance needs. While specific TAM figures are proprietary, Mesa occupies a significant niche within this broader market, focusing on specialized segments.
Upturn SWOT Analysis
Strengths
- Strong regulatory compliance and expertise
- Established reputation for quality and reliability
- Diversified product and service offerings
- Loyal customer base in critical industries
- History of successful strategic acquisitions
Weaknesses
- Reliance on a few key product lines for revenue
- Potential for integration challenges with acquisitions
- Smaller scale compared to some larger diversified competitors
- Subject to the financial health of its core customer industries
Opportunities
- Expansion into emerging markets
- Development of new innovative products and technologies
- Increased outsourcing of quality control and calibration services
- Further consolidation within the fragmented sterilization and validation market
- Growth in biopharmaceutical manufacturing
Threats
- Intensifying competition from established and emerging players
- Changes in regulatory standards and requirements
- Economic downturns impacting customer spending
- Technological obsolescence of existing products
- Supply chain disruptions impacting manufacturing
Competitors and Market Share
Key Competitors
- 3M Company (MMM)
- STERIS plc (STE)
- Avantor, Inc. (AVTR)
Competitive Landscape
Mesa Laboratories competes with larger, more diversified companies as well as specialized niche players. Its competitive advantages stem from its focus on specific quality control and calibration solutions, deep regulatory understanding, and agility in responding to customer needs. However, larger competitors may have greater resources for R&D and broader market reach.
Major Acquisitions
A-VAC Industries
- Year: 2021
- Acquisition Price (USD millions):
- Strategic Rationale: Acquired to expand its offerings in sterilization validation and gas sterilization products.
HealthMark Group
- Year: 2022
- Acquisition Price (USD millions):
- Strategic Rationale: Acquired to enhance its presence in the sterile processing and healthcare compliance market.
Growth Trajectory and Initiatives
Historical Growth: Mesa Laboratories has demonstrated consistent historical growth, fueled by both organic expansion of its existing product lines and strategic acquisitions that broaden its market presence and product capabilities.
Future Projections: Future projections are typically based on analyst estimates, which often anticipate continued revenue and earnings growth, supported by the stable demand in its target industries and potential for further market penetration.
Recent Initiatives: Recent initiatives likely involve integration of acquired businesses, expansion of manufacturing capacity, and development of new product offerings to address evolving industry needs and regulatory landscapes.
Summary
Mesa Laboratories Inc. is a well-established provider of critical quality control and calibration products and services, particularly strong in sterilization validation for healthcare and pharmaceuticals. Its consistent financial performance, strategic acquisitions, and deep regulatory expertise are key strengths. However, it must navigate intense competition and evolving regulatory landscapes to maintain its growth trajectory.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Mesa Laboratories Inc. Official SEC Filings (10-K, 10-Q)
- Company Investor Relations Website
- Financial News and Analysis Platforms (e.g., Yahoo Finance, Bloomberg)
- Industry Reports
Disclaimers:
This JSON output is for informational purposes only and does not constitute financial advice. Market share data and acquisition prices may be estimates or not publicly disclosed. Users should conduct their own due diligence before making any investment decisions. Financial data should be verified with official company filings.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Mesa Laboratories Inc
Exchange NASDAQ | Headquaters Lakewood, CO, United States | ||
IPO Launch date 1995-01-25 | CEO, President & Director Mr. Gary M. Owens | ||
Sector Technology | Industry Scientific & Technical Instruments | Full time employees 730 | Website https://www.mesalabs.com |
Full time employees 730 | Website https://www.mesalabs.com | ||
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.